These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38829016)

  • 1. The prevalence, epidemiological characteristics and mortality trends of inflammatory myopathies patients in Oman: the Prevision study.
    Al Adhoubi NK; Liyanage P; Al Salmi I; Abdul Hameed Z; Al Abrawi S; Al Lawati T; Almouslem A; Al Ghafri A; Al Shamsi A; Alismaeili Z; Al Mashaani M; Al Lawati B; Al Kalbani H; Al Kaabi J; Amayri A; Al Sariri A
    Clin Exp Rheumatol; 2024 Jul; 42(7):1333-1342. PubMed ID: 38829016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.
    Cho SK; Kim H; Myung J; Nam E; Jung SY; Jang EJ; Yoo DH; Sung YK
    J Korean Med Sci; 2019 Mar; 34(8):e55. PubMed ID: 30833879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
    Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
    Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
    Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
    Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of idiopathic inflammatory myopathies in South Africa.
    Chinniah KJ; Mody GM
    Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyositis is a rare and favourable outcome subtype of idiopathic inflammatory myopathy in Chinese patients.
    Sun C; Tian X; Yang H; Yang H; Li S; Jiang W; Peng Q; Wang G; Lu X
    Clin Exp Rheumatol; 2024 Feb; 42(2):302-308. PubMed ID: 38488095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Risk and Mortality in Hospitalized Patients With Idiopathic Inflammatory Myopathies in Western Australia.
    Nossent JC; Keen H; Preen D; Inderjeeth C
    J Rheumatol; 2024 Apr; 51(4):396-402. PubMed ID: 38302176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological profile of dermatomyositis and polymyositis: a study conducted in the Department of Rheumatology in Marrakech].
    Errafia S; Mougui A; Bouchti IE
    Pan Afr Med J; 2021; 38():101. PubMed ID: 33889267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myositis-Specific Antibodies and Myositis-Associated Antibodies in Patients With Idiopathic Inflammatory Myopathies From the PANLAR Myositis Study Group.
    González-Bello Y; Garcia-Valladares I; Reyes-Pérez IV; García-Cerda D; Medrano-Ramírez G; Navarro-Zarza JE; Andrade-Ortega L; Maradiaga-Ceceña M; Cardenas-Anaya A; Nava-Zavala AH; Orozco-Barocio G; Vázquez-Del Mercado M; Rojo-Mejia A; Loyo E; Gottschalk P; Iglesias-Gamarra A; Vega K; Rojas C; Mantilla R; Gómez G; García-Kutzbach A; Fritzler MJ; García-De La Torre I
    J Clin Rheumatol; 2021 Dec; 27(8):e302-e306. PubMed ID: 32084069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
    Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
    Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine Registry of Inflammatory Myopathies of the Argentine Society of Rheumatology.
    Gómez GN; Pérez N; Braillard Poccard A; Gómez RA; Costi AC; García MA; Viola M; Benitez A; Aciar MM; Crespo Espíndola M; Yucra D; Cosatti MA; Pisoni C; Capelusnik D; Lojo MN; Barrios BI; Rivero M; Kisluk B; Granel A
    Clin Rheumatol; 2021 Nov; 40(11):4473-4483. PubMed ID: 34159491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
    Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
    Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
    Jinnin M; Ohta A; Ishihara S; Amano H; Atsumi T; Fujimoto M; Kanda T; Kawaguchi Y; Kawakami A; Mimori A; Mimori T; Mimura T; Muro Y; Sano H; Shimizu J; Takeuchi T; Tanaka Y; Yamamoto K; Sumida T; Kohsaka H;
    Ann Rheum Dis; 2020 Mar; 79(3):387-392. PubMed ID: 31694813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spectrum of idiopathic inflammatory myopathies in Western Australia: epidemiological characteristics and mortality over time.
    Nossent J; Keen H; Preen DB; Inderjeeth CA
    Rheumatol Int; 2024 Feb; 44(2):329-337. PubMed ID: 37819456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.
    Parker MJS; Oldroyd A; Roberts ME; Lilleker JB; Betteridge ZE; McHugh NJ; Herrick AL; Cooper RG; Chinoy H
    Rheumatology (Oxford); 2019 Mar; 58(3):468-475. PubMed ID: 30496561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.
    Zhang X; Yang X; Ji L; Zhang Z
    Int J Rheum Dis; 2019 Jul; 22(7):1278-1282. PubMed ID: 31124267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic inflammatory myopathies - myositis.
    Dorph C; Lundberg IE
    Best Pract Res Clin Rheumatol; 2002 Dec; 16(5):817-32. PubMed ID: 12473276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.